Skip to main content

Advertisement

Log in

Fluorodeoxyglucose-Positron Emission Tomography in Adenocarcinomas of the Distal Esophagus and Cardia

  • World Progress in Surgery
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Adenocarcinomas of the esophagogastric junction (AEG) are now recognized as a separate tumor entity with increasing incidence. The aim of the present study was to evaluate whether positron emission tomography (PET) using the glucose analog F-18-fluorodeoxyglucose (FDG) can be used for metabolic characterization of this tumor type. Fifty-two patients with histologically proven, locally advanced AEG (distal esophagus, type I: n = 31; cardia, type II: n = 21) were studied by FDG-PET. None of the tumors had been previously treated. Findings of endoscopy (growth type), endoluminal ultrasound (uT, uN), computed tomography (cN, cranio-caudal extent, tumor thickness), histological evaluation (Lauren classification, tumor grade), anatomical classification, and survival were correlated with the results of FDG-PET. There was no correlation between FDG uptake and clinical stage, grade, Lauren classification, or survival. All AEG I tumors were visualized by FDG-PET with high contrast, whereas FDG uptake by five AEG II tumors (24%) did not differ from background activity. In a quantitative analysis, mean FDG uptake of AEG I tumors was 1.6 times higher than that of AEG II tumors (p = 0.0005). PET can be used to visualize type I adenocarcinomas of the esophagogastric junction (AEG I). In AEG II tumors, however, the use of FDG-PET appears to be limited. The significantly higher FDG uptake of AEG I tumors compared to AEG II tumors suggests that these two tumor types differ in glucose utilization. This finding strengthens the hypothesis that AEG I and AEG II are two different tumor entities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.

Similar content being viewed by others

References

  1. O Warburg (1930) The Metabolism of Tumors Constable London

    Google Scholar 

  2. AJ Fischman NM Alpert (1993) ArticleTitleFDG-PET in oncology: There‘s more to it than looking at pictures J. Nucl. Med. 34 6–11 Occurrence Handle1:STN:280:ByyC3MrotFA%3D

    CAS  Google Scholar 

  3. P Rigo P Paulus BJ Kaschten et al. (1996) ArticleTitleOncological applications of positron emission tomography with fluorine-18 fluorodesoxyglucose Eur. J. Nucl. Med. 23 1641–1674 Occurrence Handle1:STN:280:ByiD1czmslI%3D

    CAS  Google Scholar 

  4. H Prôuer W Weber W Römer et al. (1998) ArticleTitleEvaluation of pulmonary nodules by positron emission tomography using the glucose analogue fluorine-18-fluorodeoxyglucose (FDG). A controlled prospective study in 50 patients Br. J. Surg. 85 1506–1511 Occurrence Handle10.1046/j.1365-2168.1998.00915.x Occurrence Handle9823912

    Article  PubMed  Google Scholar 

  5. RL Wahl RL Cody G Hutchins et al. (1991) ArticleTitlePrimary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose Radiology 179 765–770 Occurrence Handle1:STN:280:By6B38jkvFI%3D Occurrence Handle2027989

    CAS  PubMed  Google Scholar 

  6. F Moog M Bangerter J Kotzerke et al. (1998) ArticleTitle18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow J. Clin. Oncol. 16 603–609 Occurrence Handle1:STN:280:DyaK1c7ivFamsg%3D%3D

    CAS  Google Scholar 

  7. W Römer AR Hanauske S Ziegeler et al. (1998) ArticleTitlePositron emission tomography in non-Hodgkin lymphoma: assessment of chemotherapy with fluorodeoxyglucose Blood 91 4464–4471 Occurrence Handle1:STN:280:DyaK1c3ot1WrtQ%3D%3D Occurrence Handle9616140

    CAS  PubMed  Google Scholar 

  8. P Lindholm S Leskinen-Kallio H Minn et al. (1993) ArticleTitleComparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer J. Nucl. Med. 34 1711–1716 Occurrence Handle1:STN:280:ByuD3Mrkt1E%3D

    CAS  Google Scholar 

  9. DN Jones GB McCowage HD Sostman et al. (1996) ArticleTitleMonitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET J. Nucl. Med. 37 1438–1444 Occurrence Handle1:CAS:528:DyaK28XlvF2msLc%3D

    CAS  Google Scholar 

  10. DTM Lai M Fulham MS Stephen et al. (1996) ArticleTitleThe role of whole-body positron emission tomography with [18F] fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver Arch. Surg. 131 703–707 Occurrence Handle1:STN:280:BymB1M%2FkvVU%3D

    CAS  Google Scholar 

  11. M Findlay H Young H Cunningham et al. (1996) ArticleTitleNoninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastasis: correlation with tumor response to fluorouracil J. Clin. Oncol. 14 700–708 Occurrence Handle1:CAS:528:DyaK28Xit1Gjsrk%3D

    CAS  Google Scholar 

  12. C Hofer C Laubenbacher T Block et al. (1999) ArticleTitleFluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy Eur. Urol. 36 31–35 Occurrence Handle1:STN:280:DyaK1M3psVOiuw%3D%3D

    CAS  Google Scholar 

  13. JF Vansteenkiste SG Stroobants PJ Dupont et al. (1999) ArticleTitlePrognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases. Leuven Lung Cancer Group J. Clin. Oncol. 17 3201–3206 Occurrence Handle1:STN:280:DyaK1MvjvVWruw%3D%3D

    CAS  Google Scholar 

  14. M Oshida K Uno M Suzuki et al. (1998) ArticleTitlePredicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose Cancer 82 2227–2234 Occurrence Handle1:STN:280:DyaK1c3nt1agtg%3D%3D Occurrence Handle9610703

    CAS  PubMed  Google Scholar 

  15. GW Couper D McAteer F Wallis et al. (1998) ArticleTitleDetection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer Br. J. Surg. 85 1403–1406 Occurrence Handle10.1046/j.1365-2168.1998.00963.x Occurrence Handle1:STN:280:DyaK1cvltlartA%3D%3D Occurrence Handle9782025

    Article  CAS  PubMed  Google Scholar 

  16. D McAteer F Wallis G Couper et al. (1999) ArticleTitleEvaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma Br. J. Radiol. 72 525–529 Occurrence Handle1:STN:280:DC%2BD3c%2FisVWhsA%3D%3D Occurrence Handle10560332

    CAS  PubMed  Google Scholar 

  17. P Flamen A Lerut E Cutsem ParticleVan et al. (2000) ArticleTitleThe utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer J. Thorac. Cardiovasc. Surg. 120 1085–1092 Occurrence Handle1:STN:280:DC%2BD3M%2FntF2ntA%3D%3D

    CAS  Google Scholar 

  18. P Flamen A Lerut E Cutsem ParticleVan et al. (2000) ArticleTitleUtility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma J. Clin. Oncol. 18 3202–3210 Occurrence Handle1:STN:280:DC%2BD3cvotlentw%3D%3D Occurrence Handle10986052

    CAS  PubMed  Google Scholar 

  19. FL Flanagan F Dehdashti BA Siegel et al. (1997) ArticleTitleStaging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography Am. J. Roentgenol. 168 417–424 Occurrence Handle1:STN:280:ByiC28fmt1E%3D

    CAS  Google Scholar 

  20. AC Kole JT Plukker OE Nieweg et al. (1998) ArticleTitlePositron emission tomography for staging of oesophageal and gastroesophageal malignancy Br. J. Cancer 78 521–527 Occurrence Handle1:STN:280:DyaK1cznvFyqtw%3D%3D

    CAS  Google Scholar 

  21. JR Siewert HJ Stein (1998) ArticleTitleClassification of the adenocarcinoma of the oesophagogastric junction Br. J. Surg. 85 1457–1459 Occurrence Handle1:STN:280:DyaK1M%2FjvFGjug%3D%3D

    CAS  Google Scholar 

  22. G DiChiro J Hatazawa DA Katz et al. (1987) ArticleTitleGlucose utilisation by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study Radiology 165 521–526

    Google Scholar 

  23. J Okada K Yoshikawa K Imazeki et al. (1991) ArticleTitleThe use of FDG-PET in the detection and management of malignant lymphoma: correlation and uptake with prognosis J. Nucl. Med. 32 686–691 Occurrence Handle1:STN:280:By6C1MzotVw%3D Occurrence Handle2013808

    CAS  PubMed  Google Scholar 

  24. LP Adler HF Blair JT Makley et al. (1991) ArticleTitleNoninvasive grading of muscoloskeletal tumors using PET J. Nucl. Med. 32 1508–1512 Occurrence Handle1:STN:280:By6A3s3mvFI%3D

    CAS  Google Scholar 

  25. T Fukunga S Okazumi Y Koide et al. (1998) ArticleTitleEvaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose PET J. Nucl. Med. 39 1002–1007 Occurrence Handle9627333

    PubMed  Google Scholar 

  26. BPL Wijnhoven PD Siersema WCJ Hop et al. (1999) ArticleTitleAdenocarcinomas of the distal esophagus and gastric cardia are one clinical entity Br. J. Surg. 86 529–535 Occurrence Handle1:STN:280:DyaK1M3jtlOktA%3D%3D

    CAS  Google Scholar 

  27. RJ Kalish PE Clancy MB Orringer et al. (1984) ArticleTitleClinical, epidemiologic and morphologic comparison between adenocarcinomas arising in Barrett’s esophageal mucosa and in the gastric cardia Gastroenterology 86 461–467 Occurrence Handle1:STN:280:BiuC3cbktF0%3D

    CAS  Google Scholar 

  28. GWB Clark TC Smyrk P Burdiles et al. (1994) ArticleTitleIs Barrett’s metaplasia the source of adenocarcinomas of the cardia Arch. Surg. 129 609–614 Occurrence Handle1:STN:280:ByuB28zjs1Y%3D

    CAS  Google Scholar 

  29. Schneider PM, Schweighart P, Stöltzing O et al. (1997) “Molecular evidence that cancer of the gastric cardia is different from Barrett’s cancer and related to proximal third gastric cancer” In: Siewart, JR, Roder, JD (editors), 2nd International Gastric Cancer Congress, Book of Abstracts 6:Abstract 0549

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ott, K., Weber, W., Fink, U. et al. Fluorodeoxyglucose-Positron Emission Tomography in Adenocarcinomas of the Distal Esophagus and Cardia. World J. Surg. 27, 1035–1039 (2003). https://doi.org/10.1007/s00268-003-7058-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-003-7058-9

Keywords

Navigation